Related Experiment Videos
[Specific immunotherapy in inhalative allergy to rat epithelium]
I Hansen1, K Hörmann, L Klimek
1HNO-Universitätsklinik Mannheim, Ruprecht-Karls-Universität Heidelberg.
Laryngo- Rhino- Otologie
|August 19, 2004
Summary
Specific immunotherapy effectively treated a biologist's severe allergy to rat epithelium. This allergy treatment led to complete symptom relief, enabling her to continue her vital work without allergic reactions.
Area of Science:
- Allergy and Immunology
- Occupational Health
Background:
- Specific immunotherapy is the only causal treatment for allergies besides avoidance.
- Treatment efficacy hinges on allergen type, extract quality, dosage, and schedule.
Observation:
- A biologist experienced severe rhinoconjunctivitis and asthma due to inhalant allergy to rat epithelium.
- The patient's profession required regular work with laboratory rats, making allergen avoidance impossible.
Findings:
- Rush immunotherapy was administered inpatient, followed by outpatient maintenance injections.
- Within months, the patient reported symptom relief, with decreased total IgE and specific IgE to rat epithelium.
- After 18 months, specific IgE was undetectable, and the patient was asymptomatic.
Implications:
- Specific immunotherapy can be a viable treatment option for uncommon allergies.
- Successful immunotherapy enabled the patient to continue her profession without allergy-related limitations.